Basics C4 Therapeutics, Inc. IPO Date: October 2, 2020 Sector: Healthcare Industry: Biotech Market Cap: $236.39M Activated in VL: True Average Daily Range Avg Daily Range: $0.48 | 3.96% Avg Daily Range (30 D): $0.14 | 5.42% Avg Daily Range (90 D): $0.11 | 5.06% Institutional Daily Volume Avg Daily Volume: 1.36M Avg Daily Volume (30 D): 2.41M Avg Daily Volume (90 D): 1.68M Trade Size Avg Trade Size (Sh.): 139 Avg Trade Size (Sh.) (30 D): 206 Avg Trade Size (Sh.) (90 D): 192 Institutional Trades Total Inst.Trades: 1,045 Avg Inst. Trade: $1.93M Avg Inst. Trade (30 D): $1.98M Avg Inst. Trade (90 D): $1.92M Avg Inst. Trade Volume: .2M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.19M Avg Closing Trade (30 D): $.69M Avg Closing Trade (90 D): $3.91M Avg Closing Volume: 186.33K     News Sep 15, 2025 @ 10:33 PM Why C4 Therapeutics Stock Crushed the Market on Mo... Source: Eric Volkman May 7, 2025 @ 11:00 AM C4 Therapeutics Reports First Quarter 2025 Financi... Source: C4 Therapeutics Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight Jan 9, 2025 @ 3:53 PM NUT Midline Carcinoma Treatment Market Research Re... Source: Researchandmarkets.Com Dec 8, 2024 @ 5:30 PM C4 Therapeutics Presents Cemsidomide Phase 1 Data ... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.37 $-.37 Diluted EPS $-.37 $-.37 Revenue $ $ 6.46M $ 7.24M Gross Profit $ $ $ Net Income / Loss $ $ -26.02M $ -26.32M Operating Income / Loss $ $ -28.5M $ -29.16M Cost of Revenue $ $ $ Net Cash Flow $ $ 26.86M $ -4.21M PE Ratio